General Session

EPIC-SEC 2017

The Landscape of Cardiovascular Medicine: Innovation, Leadership and Practice

Friday, April 21
7:30 AM - 9:00 AM

David J. Moliterno

Chairman, Department of Internal Medicine
University of Kentucky
University of Kentucky

Dr. David J. Moliterno is Chairman of Internal Medicine at the University of Kentucky. He has been involved with interventional cardiology for more than 20 years. Dr. Moliterno has helped lead numerous large-scale clinical trials involving over $1 billion dollars in clinical research. He was the Editor-in-Chief for CathSAP-3 and CathSAP-4 as is to be the next Editor-in-Chief of JACC: Cardiovascular Interventions. He is the author or coauthor of over 350 publications, including 60 book chapters, and editor of 7 textbooks. He has been the primary author of publications in Annals of Internal Medicine, Circulation, JACC, JAMA, Lancet, BMJ, and the New England Journal of Medicine.

Send Email for David Moliterno

Stephan Windecker

Professor and Chairman
Department of Cardiology, Bern University Hospital
Bern University

Since 2015, Prof. Windecker has been the Chairman and Director of the Department of Cardiology at the Swiss Cardiovascular Center Bern, Switzerland. He is an interventional cardiologist by training and has previously served as Director of Invasive Cardiology at Bern University Hospital from 2002 to 2015. He is full Professor of Cardiology at the University of Bern, Switzerland and executive board member of the Clinical Trials Unit at Bern University Hospital. Prof. Windecker is currently Chairman of the Clinical Practice Guidelines Committee of the European Society of Cardiology . He is also one of the course directors of EuroPCR and PCR London Valves. Prof. Windecker has been a Fulbright scholar and received the I2-summit Innovator 2005 Award of the American College of Cardiology.
Prof. Windecker’s main research interests focus on the evaluation of intracoronary devices for the treatment of coronary artery disease, research related to structural heart disease including transcatheter aortic, mitral, and tricuspid valve interventions, patent foramen ovale (PFO), left atrial appendage occlusion as well as percutaneous left ventricular assist devices.

Send Email for Stephan Windecker

H. Vernon Anderson

Professor of Medicine
University of Texas Health Science Center, McGovern Medical School
University of Texas at Houston, McGovern Medical School

Dr. Anderson is Professor of Medicine in the Cardiology Division at the University of Texas Health Science Center, McGovern Medical School, in Houston. His interests include acute coronary syndromes and ischemic heart disease, as well as clinical outcomes research in all cardiovascular interventions. Dr. Anderson received his medical degree from Emory University, where he also undertook his cardiology and interventional fellowships. For 11 years Dr. Anderson was an Associate Editor of the journal Circulation, the premier scientific journal published by the American Heart Association. Currently he serves as an Associate Editor of JACC–Cardiovascular Interventions. Dr. Anderson is a past member of the ACC-NCDR Management Board, which oversees some of the largest cardiovascular databases in the world.

Send Email for H. Vernon Anderson

Peter C. Block

Chief of Anesthesiology, Atlanta VAMCChief, Critical Care, Department of AnesthesiologyVice-Chair for Clinical Research, Department of Biomedical InformaticsMedical Director, Emory ECMO Center and EUH 4a5a ICU
Emory University Hospital
Emory University

Dr. Peter Block is a Professor in the Cardiology Division of Emory University Hospital. He is an interventional cardiologist with special interest in structural heart disease beginning with aortic and mitral valvuloplasty and ending in current clinical trials of transcatheter therapies of valve disease. His bibliography contains more than 250 publications and 45 book chapters.

Send Email for Peter Block

Amir Lerman

Mayo Clinic

Amir Lerman, MD. Is a professor of medicine and a consultant in the department of cardiovascular disease at the Mayo graduate school of medicine. Dr. Lerman serves as an associate chair of the department and the director of the cardiovascular research center at Mayo Clinic and the medical director of the Mayo-Israeli start up companies initiative. Dr. Lerman graduated from the Technion school of Medicine in Haifa Israel and completed his training in internal medicine, cardiovascular diseases and invasive cardiology at the Mayo Clinic. Dr. Leman interest is coronary physiology and imaging, regenerative medicine and digital health.
Dr. Lerman published more than 550 manuscripts, book chapters and reviews; the NIH, AHA, and several foundations support his research










Send Email for Amir Lerman

C Michael M. Valentine

Centra Americian College of Cardiology

Mike Valentine is an interventional cardiologist at Centra Health in Lynchburg, VA. He is a graduate of the University of Georgia, where he was named the outstanding senior, and the University of Virginia School of Medicine. He completed his medicine and cardiology training at Emory University in Atlanta, GA. Valentine has served the College in many roles, including ACC Treasurer and Secretary, chair of the ACC Board of Governors, and governor of the ACC’s Virginia Chapter. He was co-chair of the ACC Advocacy Committee and served on the task force to develop the Cardiac Cath Lab Quality Tool Kit. He chaired the ACC Medical Directors Institute, which promoted collaboration between payers and physicians, and developed the concept of appropriate use. He helped develop and co-chair the College’s annual Cardiovascular Summit, and currently serves as ACC Vice President. He is married to Shannon Valentine, a former member of the Virginia House of Delegates, and has three active college-aged children. Vice President: C. Michael Valentine, MD, FACC

Send Email for C Michael Valentine

David X. Zhao

Chief, Cardiovascular Medicine; Executive Director, Heart and Vascular Center
Wake Forest Baptist Health
Wake Forest School of Medicine

Dr. David Zhao is a Professor of Medicine and Surgery, Chief of Cardiovascular Medicine, and Executive Director of the Heart and Vascular Center at Wake Forest Baptist Medical Center in Winston-Salem, NC. He is an interventional cardiologist with extensive experience in the field of interventional management of coronary artery and congential and structural heart diseases. His main research interests are hybrid revascularization, cardiac stem cell therapy, and percutaneous valvular disease intervention. He has performed a series of studies in those areas and has participated in many clinical trials.

Send Email for David Zhao


Assets

The Landscape of Cardiovascular Medicine: Innovation, Leadership and Practice



Attendees who have favorited this

Send Email for The Landscape of Cardiovascular Medicine: Innovation, Leadership and Practice